TY - JOUR T1 - The Intersection of Obesity and Behavioral Addictions: A Comprehensive Narrative Review of Neurobiological Mechanisms and Clinical Implications AU - Araç, Eşref PY - 2025 DA - November Y2 - 2025 DO - 10.56016/dahudermj.1793707 JF - DAHUDER Medical Journal JO - DAHUDER MJ PB - DAHUDER WT - DergiPark SN - 2791-9250 SP - 148 EP - 154 VL - 5 IS - 4 LA - en AB - Objectives: Obesity is a pervasive global health challenge with a complex etiology. Recent conceptualizations propose that certain eating behaviors, particularly towards ultra-processed foods, mirror the patterns seen in substance use disorders, giving rise to the “food addiction” model. This narrative review aims to synthesize contemporary evidence on the neurobiological and psychological overlap between obesity and behavioral addictions, and to discuss diagnostic tools and treatment modalities informed by this model. Methods: A narrative review of literature published between 2018 and 2025 was conducted, focusing on studies elucidating the reward pathway dysfunctions, psychological correlates, and advancements in treating addiction-like eating behaviors. Results: Evidence indicates that hyperpalatable foods significantly alter the brain’s reward circuitry, notably through dopamine release and receptor downregulation in the mesolimbic pathway, paralleling mechanisms in substance addiction. Neuroimaging studies consistently show altered prefrontal-striatal connectivity, contributing to diminished inhibitory control and heightened cue reactivity. Psychologically, traits such as impulsivity and stress-mediated emotional eating are strongly associated with compulsive consumption patterns. The Yale Food Addiction Scale (YFAS) has emerged as a key tool for identifying individuals who may exhibit these addictivelike eating behaviors. Pharmacological interventions like GLP-1 receptor agonists and naltrexone/bupropion, alongside cognitive-behavioral therapies and neuromodulation techniques, show promising efficacy by targeting these underlying addictive mechanisms. Conclusion: The behavioral addiction model provides a valuable framework for understanding and treating a distinct subgroup of obesity characterized by compulsive overeating. Integrating addiction-based approaches into obesity management, including novel pharmacotherapies, psychotherapy, and public health policies regulating ultra-processed foods, offers a promising multidisciplinary strategy for improving outcomes in treatment-resistant cases. KW - Behavioral addiction KW - Dopamine KW - Food addiction KW - Obesity KW - Reward system KW - Yale food addiction scale CR - 1. World Health Organization. Obesity and overweight [Internet]. 2022 [cited 2024 March 15]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight CR - 2. Gearhardt AN, Bueno NB, DiFeliceantonio AG, Roberto CA, Jiménez-Murcia S, Fernandez-Aranda F. Social, clinical, and policy implications of ultra-processed food addiction. BMJ. 2023;383:e075354. doi:10.1136/bmj-2023-075354. CR - 3. Volkow ND, Wang GJ, Baler RD. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci. 2011;15(1):37-46. doi:10.1016/j.tics.2010.11.001. CR - 4. DiFeliceantonio AG, Coppin G, Rigoux L, Edwin Thanarajah S, Dagher A, Tittgemeyer M, et al. Supraadditive effects of combining fat and carbohydrate on food reward. Cell Metab. 2018;28(1):33-44.e3. doi:10.1016/j.cmet.2018.05.018. CR - 5. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, et al. Brain dopamine and obesity. Lancet. 2001;357(9253):354-7. doi:10.1016/S0140-6736(00)03643-6. CR - 6. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev. 1993;18(3):247-91. doi:10.1016/0165-0173(93)90013-p. CR - 7. Stice E, Yokum S. Neural vulnerability factors that predict future weight gain. Curr Obes Rep. 2021;10(4):435-43. doi:10.1007/s13679-021-00455-9. CR - 8. Kim SH, Chung JH, Kim TH, Lim SH, Kim Y, Lee YA, et al. The effects of repetitive transcranial magnetic stimulation on eating behaviors and body weight in obesity: a randomized controlled study. Brain Stimul. 2018;11(3):528-35. doi:10.1016/j.brs.2017.11.020. CR - 9. He Q, Huang X, Zhang S, Turel O, Ma L, Bechara A. Dynamic causal modeling of insular, striatal, and prefrontal cortex activities during a food-specific Go/NoGo task. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4(12):1080-9. doi:10.1016/j.bpsc.2018.12.005. CR - 10. Shepherd GM. Smell images and the flavour system in the human brain. Nature. 2006;444(7117):316-21. doi:10.1038/nature05405. CR - 11. Stevenson RJ. An initial evaluation of the functions of human olfaction. Chem Senses. 2010;35(1):3-20. doi:10.1093/chemse/bjp083. CR - 12. Bragulat V, Dzemidzic M, Bruno C, Cox CA, Talavage T, Considine RV, et al. Food-related odor probes of brain reward circuits during hunger: a pilot fMRI study. Obesity. 2010;18(8):1566-71. doi:10.1038/oby.2010.57. CR - 13. Boswell RG, Kober H. Food cue reactivity and craving predict eating and weight gain: a meta-analytic review. Obes Rev. 2016;17(2):159-77. doi:10.1111/obr.12354. CR - 14. van der Laan LN, de Ridder DT, Viergever MA, Smeets PA. The first taste is always with the eyes: a meta-analysis on the neural correlates of processing visual food cues. Neuroimage. 2011;55(1):296-303. doi:10.1016/j.neuroimage.2010.11.055. CR - 15. Higgs S, Spetter MS. Cognitive control of eating: the role of memory in appetite and weight gain. Curr Obes Rep. 2018;7(1):50-9. doi:10.1007/s13679-018-0296-9. CR - 16. Davis C, Patte K, Levitan R, Reid C, Tweed S, Curtis C. From motivation to behaviour: a model of reward sensitivity, overeating, and food preferences in the risk profile for obesity. Appetite. 2007;48(1):12-9. doi:10.1016/j.appet.2006.05.016. CR - 17. Moreno-López L, Contreras-Rodríguez O, Soriano-Mas C, Stamatakis EA, Verdejo-García A. Disrupted functional connectivity in adolescent obesity. Neuroimage Clin. 2016;12:262-8. doi:10.1016/j.nicl.2016.07.005. CR - 18. Epel E, Lapidus R, McEwen B, Brownell K. Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology. 2001;26(1):37-49. doi:10.1016/S0306-4530(00)00035-4. CR - 19. World Health Organization. Policies to address ultraprocessed food consumption [Internet]. 2024 [cited 2024 Mar 15]. Available from: https://www.who.int/publications/i/item/9789240072158. CR - 20. Cornelis MC, Flint A, Field AE, Kraft P, Han J, Rimm EB, et al. A genome-wide investigation of food addiction. Obesity. 2016;24(6):1336-41. doi:10.1002/oby.21476. CR - 21. Stice E, Yokum S. Gain in body fat is associated with increased striatal response to palatable food cues, whereas body fat stability is associated with decreased striatal response. J Neurosci. 2016;36(26):6949-56. doi:10.1523/JNEUROSCI.4365-15.2016. CR - 22. Gearhardt AN, Corbin WR, Brownell KD. Preliminary validation of the Yale Food Addiction Scale. Appetite. 2009;52(2):430-6. doi:10.1016/j.appet.2008.12.003. CR - 23. Ziauddeen H, Farooqi IS, Fletcher PC. Obesity and the brain: how convincing is the addiction model? Nat Rev Neurosci. 2012;13(4):279-86. doi:10.1038/nrn3212. CR - 24. Schulte EM, Smeal JK, Gearhardt AN. Foods are differentially associated with subjective effect report questions of abuse liability. PLoS One. 2017;12(8):e0184220. doi:10.1371/journal.pone.0184220. CR - 25. Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010;376(9741):595-605. doi:10.1016/S0140-6736(10)60888-4. CR - 26. Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183. CR - 27. Urva S, Coskun T, Loh MT, Du Y, Thomas MK, Gurbuz S, et al. LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebocontrolled, randomised, multiple-ascending dose trial. Lancet. 2022;400(10366):1869-81. doi:10.1016/S0140-6736(22)02033-5. CR - 28. Cooper Z, Fairburn CG. A new cognitive behavioural approach to the treatment of obesity. Behav Res Ther. 2001;39(5):499-511. doi:10.1016/S0005-7967(00)00065-6. CR - 29. Hilbert A, Petroff D, Herpertz S, Pietrowsky R, Tuschen-Caffier B, Vocks S, et al. Meta-analysis of the efficacy of psychological and medical treatments for binge-eating disorder. J Consult Clin Psychol. 2019;87(1):91-105. doi:10.1037/ccp0000358. CR - 30. Lowe CJ, Vincent C, Hall PA. Effects of noninvasive brain stimulation on food cravings and consumption: a meta-analytic review. Psychosom Med. 2017;79(1):2-13.doi:10.1097/PSY.0000000000000368. UR - https://doi.org/10.56016/dahudermj.1793707 L1 - https://dergipark.org.tr/en/download/article-file/5285950 ER -